investor.arraybiopharma.com investor.arraybiopharma.com

investor.arraybiopharma.com

Array BioPharma :: Investors :: Investors

Q4 2015 Array BioPharma Inc. Earnings Conference Call. 160;at 9:00 am ET. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (partnered with AstraZeneca). Stock Quote and Chart.

http://investor.arraybiopharma.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.ARRAYBIOPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 16 reviews
5 star
8
4 star
5
3 star
3
2 star
0
1 star
0

Hey there! Start your review of investor.arraybiopharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

FAVICON PREVIEW

  • investor.arraybiopharma.com

    16x16

CONTACTS AT INVESTOR.ARRAYBIOPHARMA.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Array BioPharma :: Investors :: Investors | investor.arraybiopharma.com Reviews
<META>
DESCRIPTION
Q4 2015 Array BioPharma Inc. Earnings Conference Call. 160;at 9:00 am ET. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (partnered with AstraZeneca). Stock Quote and Chart.
<META>
KEYWORDS
1 careers
2 menu
3 about us
4 management team
5 board of directors
6 pipeline
7 filanesib
8 binimetinib
9 selumetinib
10 clinical trials
CONTENT
Page content here
KEYWORDS ON
PAGE
careers,menu,about us,management team,board of directors,pipeline,filanesib,binimetinib,selumetinib,clinical trials,discovery collaborations,array discovery capabilities,selected collaborations,publications,investors,stock information,news and events
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Array BioPharma :: Investors :: Investors | investor.arraybiopharma.com Reviews

https://investor.arraybiopharma.com

Q4 2015 Array BioPharma Inc. Earnings Conference Call. 160;at 9:00 am ET. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (partnered with AstraZeneca). Stock Quote and Chart.

INTERNAL PAGES

investor.arraybiopharma.com investor.arraybiopharma.com
1

Array BioPharma :: Investors :: Stock Quote & Chart

http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-stockquote

Stock Quote and Chart. 160; 0.24. Data as of 08/19/16 4:15 pm ET. Minimum 20 minute delay. Open High Low Close (OHLC). Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Stock Quote and Chart.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

1

OTHER SITES

investor.ariad.com investor.ariad.com

ARIAD Pharmaceuticals, Inc: Investor home

Our Name and Logo. Our Vision, Mission and Values. Our Vision, Mission and Values. Key to long-term value: discipline, execution and consistent communication. ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer an...

investor.arinet.com investor.arinet.com

Investors — Investor Information - ARI

ARI - We Create Connections. ARI has helped us support the 9 manufacturer brands we sell which has been. Essential to our growth. Our OEM part sales are up 265%. From last year.". Mdash; Powersports Dealer. Services for the Powersports industry. Up-to-date information from all of my manufacturers is critical to my business. Working with ARI saves us more than $450 per week. In outsourcing fees while growing my parts business by 125%. Mdash; OPE Dealer. Services for the Outdoor Power Equipment industry.

investor.aripaev.ee investor.aripaev.ee

AP investor

LHV Maailma Aktsiad Fond A. LHV Maailma Aktsiad Fond B. Nordea Pensionifond Aktsiad 100. Danske Pension 100 Pluss. Mandatum Life Indonesia Index. Mandatum Life Australia Index. Mandatum Life Russia Index. Mandatum Life Brazil Index. Mandatum Life India Index. Hetkel tehinguid sooritatud pole. Nordea Pensionifond A Pluss. NASDAQ OMX Tallinna, Riia ja Vilniuse börsiinfo 15 minutilise viivisega. Info uuendamiseks kasuta "uuenda/refresh" nuppu lehe pealkirja vasakus servas.

investor.arlp.com investor.arlp.com

Alliance Resource Partners, L.P. »Overview

Safety and Technology  . Mines and Facilities  . Community Involvement  . Alliance in the Community. Career Opportunities  . Investor Relations  . About Us  . Coal: Fuel for Economic Growth. Alliance Resource Partners, L.P. Guidance Update. 160;at 11:00 am ET. Alliance Resource Partners, L.P. Guidance Update. Monday, August 3, 2015 . 11:00 am ET  . Click here for webcast. Second Quarter 2015 Alliance Resource Partners, L.P. and Alliance Holdings GP, L.P. Earnings Conference Call. 160;at 9:00 am ET. Repli...

investor.armourreit.com investor.armourreit.com

IRWeblink

Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.

investor.arraybiopharma.com investor.arraybiopharma.com

Array BioPharma :: Investors :: Investors

Q4 2015 Array BioPharma Inc. Earnings Conference Call. 160;at 9:00 am ET. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (partnered with AstraZeneca). Stock Quote and Chart.

investor.arrow.com investor.arrow.com

Arrow Investor Relations: Investor Relations Overview

Arrow Fact Sheet [PDF]. Arrow in the Community. Arrow Electronics is a global provider of products, services and solutions to industrial and commercial users of electronic components and enterprise computing solutions, with 2014 sales of $22.8 billion. Arrow serves as a supply channel partner for more than 100,000 original equipment manufacturers, contract manufacturers and commercial customers through a global network of more than 460 locations in 56 countries. Learn more about Arrow Sam Car. Form 10-K ...

investor.artecinc.net investor.artecinc.net

ABOUT US | ARTEC INC

Investor Events and Presentations. Subscribe to our monthly. Artnec, inc seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. Artnec, inc is traded on OTCQX under the ticker symbol ACTL.

investor.artemisrep.com investor.artemisrep.com

Artemis Investor Portal

2018 Artemis Real Estate Partners. This database is not available to the public and is only accessible by our partners and other qualified users.

investor.artnews.com investor.artnews.com

ARTNEWS S.A.

Abbey House Group S.A. General Meeting of Shareholders. Current and Periodic Reports. ARTNEWS in the Media. The leading source for art coverage since 1902. POLAND’S LEADING MAGAZINE ABOUT ART. WORLD’S OLDEST AND MOST WIDELY CIRCULATED. ART MAGAZINE PUBLISHED IN NEW YORK SINCE 1902. WWWARTNEWS.COM: INTELLIGENCE ON GLOBAL ART TRADE AND COLLECTING. LEADING PROVIDER OF ART INVESTMENT RESEARCH AND ANALYSIS. INTERNATIONAL, UNBIASED, DIGITAL. The leading source for art coverage since 1902. POLAND’S LEADING MAGA...

investor.asbis.com investor.asbis.com

ASBIS investor portal

More information at WSE website. February 27, 2018. ASBISc Enterprises Plc Published its Consolidated Interim Report for Q4 2017. ASBISc Enterprises Plc, a leading distributor of IT products in emerging markets of Europe, the Middle East and Africa, published its Consolidated Interim Report for Q4 2017. February 27, 2018. ASBIS Results In Q4 2017: Almost 50% Growth In Revenues And Net Profitability Year-On-Year. 357 97 633 793. 357 25 857 288. ASBIS Results in Q4 2017. Current report no 6/2017. Or stop u...